JULIETTE HOLLINGSHEAD: Open Payments
NPI 1720628308 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$333 in 17 payments from 11 companies in 2025. Trend: 2023 $245 · 2024 $901 · 2025 $333
Food & beverage: $313Education: $20
| Company | Payments | Amount |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 3 | $70 |
| Novo Nordisk Inc | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Amgen Inc. | 2 | $33 |
| Calliditas Therapeutics US Inc. | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Fresenius USA Marketing, Inc. | 1 | $26 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| SCPHARMACEUTICALS INC. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: PURIFIED CORTROPHIN GEL, Ozempic, Kerendia, TARPEYO, Vanrafia, VELPHORO, UPTRAVI, KRYSTEXXA.
Industry payments across ID — which companies pay providers there.
